Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1159 results about "Mouse Heart" patented technology

Displaying a scrollable list of affordances associated with physical activities

The present disclosure generally relates to managing user interfaces associated with physical activities. The user interface displays a scrollable list of affordances associated with physical activities. The affordances may contain physical activity and heart rate information. A user can launch a physical activity tracking function or an interface to change a workout metric using an affordance. Users can also control the music that is played in response to selecting a workout. Further, the interface can be used to compose a reply message to a received message that contains workout information. The interfaces can show a graph that includes heart data when the user's heart rate meets a heart rate alert criteria.
Owner:APPLE INC

Application of FAP-targeted CAR-T cell in preparation of medicine for treating cardiac fibrosis in chronic period of myocarditis

ActiveCN119074926AExcellent fibrosis treatment effectAntibody medical ingredientsCardiovascular disorderCardiac fibrosisMyocarditis
The invention provides an application of a CAR-T cell targeting FAP in preparation of a medicine for treating cardiac fibrosis in a myocarditis chronic stage. According to the present invention, it is found that the FAP specific CAR-T cell can effectively target the cells expressing the mouse FAP protein, the CAR-T cell can effectively remove the cells expressing the mouse FAP protein after being activated, and the chimeric antigen receptor T cell can effectively alleviate the cardiac fibrosis of the mouse at the chronic period of myocarditis, and can recover the function after the inflammation injury. The invention develops a CAR-T therapy for myocardial fibrosis caused by the chronic period of myocarditis, the chimeric antigen receptor T cell expressing the targeted fibroblast activating protein can recognize activated myocardial fibroblasts, and the cardiac fibrosis after inflammation injury can be obviously relieved and the function can be recovered.
Owner:CHINESE ACADEMY OF MEDICAL SCIENCES FUWAI HOSPITAL SHENZHEN HOSPITAL (SHENZHEN SUN YAT-SEN CARDIOVASCULAR HOSPITAL)

Three-dimensional modeling and assessment of cardiac tissue

A system for patient cardiac imaging and tissue modeling. The system includes a patient imaging device that can acquire patient cardiac imaging data. A processor is configured to receive the cardiac imaging data. A user interface and display allow a user to interact with the cardiac imaging data. The processor includes fat identification software conducting operations to interact with a trained learning network to identify fat tissue in the cardiac imaging data and to map fat tissue onto a three-dimensional model of the heart. A preferred system uses an ultrasound imaging device as the patient imaging device. Another preferred system uses an MRI or CT image device as the patient imaging device.
Owner:SOUTHERN ILLINOIS UNIVERSITY

Heart disease prediction system based on AI

The invention relates to the technical field of heart data analysis, in particular to an AI (artificial intelligence)-based heart disease prediction system, which comprises a feature relationship modeling module for mapping each type of information into a multi-dimensional feature space based on collected heart data, analyzing the condition correlation degree between feature nodes, connecting the feature nodes through correlation information, and establishing a model; and quantifying a linkage effect between the features to obtain a feature condition dependency relationship analysis result. According to the method, various types of heart health data are noded by constructing a multi-dimensional feature space, and a correlation structure is established according to condition correlation among data features. And a synergistic effect and an interdependence relationship among the features are disclosed. By analyzing the joint state probability of the feature nodes, the linkage effect of the feature combination on the overall risk is quantified, and the analysis depth of the disease risk is enhanced. In addition, by comparing the independent state probability of a single feature with the joint state probability of the feature combination, a feature combination that makes a significant contribution to the risk can be identified.
Owner:HUICAI ENTERPRISE SERVICES (JIAXING) INFORMATION TECH CO LTD

Heart pump impeller housing with cylindrical magnetic pocket and end ring and impeller bearing flushing

PCT designated stageWO2025226734A1Blood pumpsIntravenous devicesImpellerBlood pump
A mechanical circulatory support (MCS) system having an axial rotary blood pump with an impeller housing having a cylindrical pocket for receiving a magnet and closed by an end ring, requiring only a single circumferential weld and an axial weld. The impeller includes a shaft and one or more blades extending radially from the shaft. An inner and outer wall extend longitudinally from the shaft defining the pocket therebetween. A magnet array is positioned within the pocket and configured to be magnetically driven by an output shaft of a motor. The end ring is coupled to the end of the pocket opposite the shaft thereby encapsulating the magnet array within the pocket. Alignment holes may be provided within a floor of the pocket for orienting and balancing the impeller.
Owner:KARDION GMBH

Heart valve repair devices and delivery devices therefor

An implantable device or implant is configured to be positioned within a native heart valve to allow the native heart valve to form a more effective seal. The device can be deployed from a delivery system including one or more lines which can be decoupled from the device by energizing. The device can include contoured clasps which approximate the shape of the native valve when the clasps are in the closed position. The device can include a coaptation element with body portion including a plurality of struts and openings defining a lattice structure. One or more surfaces of one or more components of the device can be coated to improve the visibility of the device during deployment and implantation.
Owner:EDWARDS LIFESCIENCES CORP

Application of spermidine in preparation of medicine for preventing and treating doxorubicin-induced cardiotoxicity and myocardial aging

The invention relates to the technical field of spermidine application, in particular to application of spermidine in preparation of medicine for preventing and treating doxorubicin-induced cardiotoxicity and myocardial aging. Cell proliferation experiments and mouse survival rate experiments show that spermidine can reduce death of myocardial cells and mice caused by adriamycin; a q-PCR experiment shows that spermidine can improve abnormal expression conditions of P53, P21, P16, BAX, TNF-alpha, IFN alpha, IL-10 and IL-18 in myocardial cells caused by adriamycin; a beta-galactosidase staining experiment shows that the spermidine can reduce the condition that the expression of a marker beta-galactosidase for myocardial cell senescence induced by adriamycin is increased; a Western Blot experiment shows that the spermidine can improve the condition that the P53 protein is abnormally increased due to the adriamycin; an Elisa experiment shows that spermidine can improve the condition that myocardial injury markers cTn-I and AST and inflammatory factors IL-1beta are abnormally increased due to adriamycin, and the myocardial injury markers cTn-I and AST and inflammatory factors IL-1beta are abnormally increased due to adriamycin. Therefore, spermidine can improve cardiotoxicity and myocardial aging induced by adriamycin.
Owner:THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIV

Device for aortic root and valve visualization and aortic valve leakage measurement

Provided herein is a device for simultaneous intraoperative leak testing and visualisation of a heart valve seat, the device comprising an end cap configured to engage with and to sealingly close an opening of a tubular vascular graft, the end cap comprising a backing portion, a connector portion, a view port, and at least one fluid conduit element, the connector portion comprising a distal end dimensioned for placement inside of the opening, a first fastening element comprising an external thread, a second fastening element comprising an internal thread and configured to be rotated onto the first fastening element, and the external and internal threads are adapted such that the first and second fastening elements are fittingly engaged with the tubular vascular graft scalingly secured therebetween by less than one rotation of the second fastening element around the outer circumference.
Owner:ACADEMISCH ZIEKENHUIS LEIDEN (H O D N LUMC)

Transcatheter type artificial polymer heart valve

The transcatheter type artificial polymer heart valve comprises an integrated valve leaflet and a valve frame, the valve frame is of a hollow columnar grid structure, the valve frame is provided with a first end and a second end, the first end is provided with a plurality of stand columns at intervals in the circumferential direction, the integrated valve leaflet comprises a pipe body and a valve leaflet, the pipe body is provided with a third end and a fourth end, and the valve leaflet is arranged in the pipe body. The valve leaflets are arranged in the center of the third end, the valve leaflets are sequentially arranged in the circumferential direction, connecting grooves are formed in the connecting positions of the adjacent valve leaflets, and the connecting grooves are provided with through holes allowing the stand column to penetrate through; a connecting column is arranged on the outer wall of the pipe body, and a connecting hole matched with the connecting column is formed in the petal frame; when the integrated valve leaflet is arranged in the valve frame, the third end and the fourth end correspond to the first end and the second end respectively, the stand columns are inserted into the through holes, and the connecting columns are connected with the connecting holes in a one-to-one correspondence mode. Manual valve sewing is reduced, and the assembly efficiency is improved; stress concentration during opening and closing of the valve leaflet is reduced, and the performance of the valve is optimized.
Owner:SUZHOU HEARTHILL MEDICAL CO LTD

Specific antibody for detecting human cardiac myosin binding protein C

ActiveCN119192364AImmunoglobulins against animals/humansDisease diagnosisMyosin binding protein C, cardiacCardiac Myosins
Owner:SHANGHAI XINMIAO BIOLOGICAL TECHNOLOGY CO LTD

Heart AI system based on deep learning

The invention discloses a heart AI system based on deep learning, and relates to the technical field of medical image processing, and the heart AI system comprises a two-dimensional fully-supervised left atrium segmentation algorithm module, a three-dimensional semi-supervised left atrium segmentation algorithm module, and a whole heart segmentation algorithm module. Meanwhile, through combination of Transform and a residual network, semantic information in the image is captured in a larger visual field, so that the segmentation precision of the network is improved; a two-dimensional fully-supervised left atrium segmentation algorithm module based on axial attention is provided from a two-dimensional angle by taking UNet as a basic model, the algorithm module firstly constructs a double-layer residual error convolution module, gradient information is transmitted through a plurality of paths, then a task-driven feature enhancement module is introduced to optimize feature representation, and finally, a task-driven left atrium segmentation algorithm is constructed. A multivariate feature fusion module is designed to integrate features, and finally a feature coupling module is designed, so that the limitation of traditional convolution operation is overcome.
Owner:ZHENJIANG ZHIMING TECH CO LTD

Construction and application of human pluripotent stem cell-derived heart organoid traditional Chinese medicine extract toxicity test chip

The invention provides construction and application of a human pluripotent stem cell-derived heart organoid traditional Chinese medicine extract toxicity test chip. The chip comprises a plurality of micro-cell culture chambers and a micro-fluidic pore channel, heart organoid culture is carried out in the micro-cell culture room, culture media are added in the micro-fluidic channel to maintain the activity of the heart organoid, and traditional Chinese medicine extracts are added to evaluate the toxicity of traditional Chinese medicine. By simulating the reaction of the heart organ, the toxicity of the traditional Chinese medicine can be evaluated, the safety and effectiveness information about the traditional Chinese medicine can be provided, finally, the use of experimental animals can be reduced, and the animal welfare can be improved.
Owner:YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE

Systems and methods for delivering annuloplasty devices

The present invention relates to a system for delivering an annuloplasty device for restoring a heart valve annulus from a dysfunctional configuration to a working configuration wherein the annuloplasty device is configured to expand from a preset configuration corresponding to the working configuration of the valve annulus, the system comprising a delivery device, a delivery device is configured to be removably coupled to an annuloplasty device, where the delivery device includes a structure configured to expand from a first configuration to a second configuration, where the second configuration is substantially equal to or greater than a predetermined configuration of the annuloplasty device.
Owner:V·塔塞思

Application of rilpivirine in preparation of medicine for treating myocardial infarction

The invention discloses an application of rilpivirine (RPV) in preparation of a medicine for treating myocardial infarction, and relates to the field of medicines for treating myocardial infarction. The invention belongs to the technical field of biological medicine. According to the present invention, the acute myocardial infarction (AMI) disease mouse model is constructed through the induction of the permanent ligation of the left anterior descending branch; after rilpivirine is orally taken, the conditions of survival, heart function, structure change and the like of the AMI mouse model during X weeks after operation are observed. Results show that rilpivirine (as shown in the formula I) has the effects of remarkably improving the cardiac function of AMI injury, relieving cardiac remodeling and increasing the survival rate of AMI mice. Therefore, a new technical means is provided for treatment of myocardial infarction, and rilpivirine has a wide application prospect in treatment of myocardial infarction diseases. # imgabs0 #
Owner:DALIAN MEDICAL UNIVERSITY

Construction method of four-gene editing xenogenous organ transplantation donor pig

InactiveCN119120568AOvercome the problem of low production efficiencyPromote clinical translation applicationHydrolasesMicroorganism based processesAntigenAnimal biotechnology
The invention relates to a construction method of a four-gene editing xenogenic organ transplantation donor pig, and belongs to the technical field of animal biology. In a wild type pig fetal fibroblast cell line, a GGTA1 gene is knocked out by utilizing a CRISPR / Cas9 gene editing technology, three humanized genes of hCD39, hCD55 and hTBM are transferred, a GTKO / hCD39 / hCD55 / hTBM four-gene editing cloned pig is constructed in combination with a somatic cell nucleus transplantation technology, and four-gene editing xenogenic organ transplantation donor pigs are further obtained in batches through genotype identification and protein function phenotype analysis. According to the invention, the common problem of antigen-antibody mediated immunological rejection in a pig-human xenograft process is solved to a certain extent, and a foundation is laid for further research and development of donor pigs suitable for xenograft of organs / tissues such as heart, kidney, liver, skin and the like; the method has an important prospect for carrying out pre-clinical research on pig-non-human primate xenogeneic organ transplantation and clinical application of pig-human xenogeneic organ transplantation.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Assay for mybpc3

The present invention relates to monoclonal antibodies, or fragments thereof, which bind to MYBPC3 (Myosin binding protein C, cardiac type). Further, the present invention relates to a kit comprising the monoclonal antibodies of the present invention. In some embodiments, the kit is provided as sandwich assay. Further the present invention relates to the in vitro use of the monoclonal antibodies, or fragments thereof, or of the kit of the present invention for the detection of MYBPC3 in a sample. Moreover, the present invention relates to diagnostic methods, such as the assessment of cardiac condition, for example of myocardial infarction.
Owner:ROCHE DIAGNOSTICS GMBH

Artificial heart valve, artificial heart valve tissue calcification model as well as preparation method and application of artificial heart valve tissue calcification model

The invention belongs to the technical field of biological medicine, and particularly discloses an artificial valve tissue calcification model and a preparation method and application thereof. The preparation method comprises the following steps: providing human valvular interstitial cells; the method comprises the following steps: providing a hydrogel system, wherein the hydrogel system comprises type I collagen, fibrinogen and Matrigel matrigel; constructing an engineered heart valve tissue strip by taking the hydrogel system as a skeleton structure between valve interstitial cells; and culturing the engineered heart valve tissue strip by using a calcification induction culture solution, so that the valve tissue generates a calcification phenotype. The model provided by the invention can generate a valve calcification phenotype which is similar to that after human heart valve calcification and is represented by valve interstitial cell activation, extracellular matrix remodeling such as collagen mass secretion and calcium deposition region generation. The model provided by the invention is low in cost, can be produced in batches, meets the research on the pathogenesis of extracorporeal valve calcification, and makes up for the dilemma that no artificial valve calcification model is available for drug research and development at present.
Owner:HUBEI UNIV

Scanning triggering method, device and system and storage medium

ActiveCN119548157ASolve the problem of impossible to achieve accurate scanning triggeringOrgan movement/changes detectionUltrasonic/sonic/infrasonic dianostic techniquesComputer hardwareEngineering
The invention relates to a scanning triggering method, device and system and a storage medium, and the method comprises the steps: obtaining a heart movement signal, collected in real time, of a scanning object; judging whether newest signal data in the heart movement signal meets a preset triggering condition or not; generating a trigger instruction under the condition that the newest signal data meets a preset trigger condition; the trigger instruction is used for triggering the medical imaging equipment to perform medical scanning on the scanned object. According to the method and the device, the problem that accurate scanning triggering cannot be realized is solved, and scanning is accurately triggered by utilizing the acquired heart movement signals.
Owner:SHANGHAI UNITED IMAGING RES INST OF INTELLIGENT IMAGING +1

Application of circular RNA circSMAD3 in preparation of medicine for preventing and treating myocardial remodeling and heart failure

The invention provides application of circular RNA circSMAD3 in preparation of medicine for preventing and treating myocardial remodeling and heart failure, and belongs to the field of biological medicine, the circular RNA circSMAD3 is non-coding RNA, and the nucleotide sequence is shown as SEQ ID NO.1. The circular RNA circSMAD3 is used for overexpressing adenovirus and knocking down adenovirus based on short hairpin structure to infect primary myocardial cells and cardiac fibroblasts of mice, and the circular RNA circSMAD3 can be used for preventing and treating myocardial remodeling and heart failure. The result shows that circSMAD3 significantly inhibits cardiac hypertrophy and activation of cardiac fibroblasts. When the function of circSMAD3 is explored in vivo, circSMAD3 is overexpressed in a mouse myocardial remodeling and heart failure model induced by transverse aortic constriction (TAC) and myocardial infarction (MI) by using a caudal vein injection mode by using a 9-type adeno-associated virus (AAV9) overexpressed by circSMAD3 myocardial specificity. The result shows that the circSMAD3 overexpression can effectively relieve myocardial hypertrophy and myocardial fibrosis caused by TAC and MI, and obviously improve the cardiac function of mice. The invention provides a new medicine for preventing and treating myocardial remodeling and heart failure.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Mouse model construction method for specifically tracing heart valve cells and application

PendingCN120796387AMicroinjection basedStable introduction of DNADiseaseHeart valve disorder
The invention discloses a construction method and application of a mouse model for specifically tracing heart valve cells, and belongs to the technical field of animal model construction. The model construction method comprises the following steps: (1) constructing a Wid1-Cre hybrid mouse before inserting a Cre recombinase coding gene into a termination codon of a mouse Wid1 gene; and (2) hybridizing the Wid1-Cre hybrid mouse with the Rosa26-tdTomato homozygous report mouse, so as to obtain the double transgenic mouse which simultaneously carries the Wid1-Cre gene and the Rosa26-tdTomato gene. According to the invention, on the basis of the expression characteristic that Wif1 is only limited to a valve area in the heart, Wif1-Cre is constructed; according to the Rosa26-tdTomato mouse model, specific tracing of heart valve cells is achieved, and an important experimental tool is provided for mechanism research of heart valve diseases and development of therapeutic drugs.
Owner:ZHEJIANG UNIV +1

Coenzyme Q10-containing medicine for improving heart activity and preparation method thereof

The invention discloses a coenzyme Q10-containing medicine for improving heart activity and a preparation method thereof, and particularly belongs to the technical field of biological medicines. The medicine comprises functional components and auxiliary materials, wherein the functional components comprise a cactus extract, a calligonum mongolicum extract, an astragalus membranaceus extract, a sea-buckthorn extract and coenzyme Q10; the hypoxia survival time and the load-bearing swimming time of mice can be remarkably prolonged through low, medium and high dose groups of the medicine for improving the heart vitality, the requirement of fatigue caused by high labor intensity for oxygen is further met by enhancing the immunity of the organism, supply of nutrient substances to the brain, the heart, the bones and the muscles of the organism is enhanced, and the effect of improving the heart vitality is achieved. The composition can regulate the activity of central nervous system, promote the normal operation of the body circulation system, relieve and eliminate fatigue and damage to the body caused by fatigue and chronic fatigue, and quickly recover physical strength.
Owner:GUANGDONG RUNHE BIOTECHNOLOGY CO LTD

Leaflet design for a heart valve prosthesis

A prosthetic valve component is disclosed for a valve prosthesis. The valve component includes valve leaflets configured to be operably coupled within a frame of the valve prosthesis, wherein each valve leaflet is shaped and sized to achieve a target pinwheeling score PS. The target pinwheeling score correlates to full contact being made between free edges of the valve leaflets, when the valve leaflets are operably coupled within the frame of the valve prosthesis, such that no central opening and little to no overlap occurs between the valve leaflets.
Owner:MEDTRONIC INC

Heart valve repair devices and delivery devices therefor

A valve repair device for repairing a native valve of a patient. The valve repair device having one or more adjustable width paddle frame portions. The adjustable width paddle frame portions having an anterior portion extending from the medial side of the device to the lateral side of the device and a posterior portion extending from the medial side of the device and a lateral side of the device opposite the anterior portion. The anterior portion and the posterior portion are formed as a single frame member integrally joined at linking portions at the medial side of the device and a lateral side of the device. A connector includes attachment portions that connect to the linking portions to attach the adjustable width frame portion to the connector.
Owner:EDWARDS LIFESCIENCES CORP

Radar cardiography: a precise cardiac data reconstruction method

A precise cardiac data reconstruction method is provided, which may also be referred to herein as radar cardiography (RCG). RCG can reconstruct cardiac data, such as heart rate and / or electrocardiogram (ECG)-like heartbeat waveform signals wirelessly by using advanced radar signal processing techniques. For example, heartbeat and related characteristics can be monitored by isolating cardiovascular activity from strong respiratory interference in spatial spaces: azimuth and elevation. This results in significant improvements to pulse signal-to-noise-ratio (SNR) compared to conventional approaches, facilitating heart-rate variability (HRV) analysis.
Owner:THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA

Heart ultrasound image vision enhancement method and system

ActiveCN119130816A
The invention provides a cardiac ultrasound image vision enhancement method and system, and the method comprises the steps: calculating the structural similarity between a to-be-enhanced cardiac ultrasound image and a left-right adjacent cardiac ultrasound image, and calculating the two-dimensional entropy of the to-be-enhanced cardiac ultrasound image and the two-dimensional entropy of the left-right adjacent cardiac ultrasound image; selecting at least one reference image from the left and right adjacent cardiac ultrasound images according to the structural similarity and the two-dimensional entropy; obtaining a target search window according to the similarity with the reference image neighborhood block, the similarity with the search window and the distance between the reference image where the search window is located and the cardiac ultrasound image to be enhanced; and obtaining the value of the enhanced pixel point according to the target search window, the neighborhood block of the cardiac ultrasound image to be enhanced and the search window. According to the method, the own image is considered in heart ultrasound image enhancement, and the heart ultrasound image is enhanced according to the adjacent image, so that the enhancement effect is more obvious.
Owner:HENAN UNIV OF CHINESE MEDICINE

A contactless person identification method using heart radar signals

The present invention discloses a non-contact personnel identification method using a heart radar signal, the method comprising the following steps: S1, extracting a user reflection signal; S2, using a heartbeat signal filter to perform signal preprocessing on the user reflection signal; S3, demodulating the phase of the reflection signal that has undergone signal preprocessing to obtain a continuous reflection signal; S4, using a heartbeat segmentation algorithm on the continuous reflection signal to obtain a single heartbeat of the user; S5, using a low-pass filter to resample the single heartbeat of the user to a fixed sample length, and storing the obtained single heartbeat of the user in a database for matching. Beneficial effects: Compared with traditional authentication methods, passive contactless measurement, the present invention scans the user's heartbeat signal through a radar system, avoiding the user's direct contact with the device and active participation. At the same time, compared with biometric recognition technologies such as facial recognition, the present invention can better protect the user's personal privacy.
Owner:RES INST OF NANJING RUNNAN MEDICAL ELECTRONICS CO LTD

Echocardiography deep learning and cardiovascular outcomes

PCT designated stage expiredWO2025081112A1Image enhancementImage analysisMedicineUltrasonic cardiography
Echocardiography deep learning and cardiovascular outcomes are described. An echocardiogram analysis module may include a deep learning model to generate a video output for an input echocardiogram video, the deep learning model comprising a convolutional neural network and at least one dense layer. The echocardiogram analysis module may further include a cardiac prediction generator to generate a cardiac prediction based on video outputs generated for a plurality of input echocardiogram videos of an echocardiogram study, the cardiac prediction comprising a measurement prediction or a classification prediction.
Owner:THE GENERAL HOSPITAL CORP +2

Echocardiography Deep Learning and Cardiovascular Outcomes

Echocardiography deep learning and cardiovascular outcomes are described. An echocardiogram analysis module may include a deep learning model to generate a video output for an input echocardiogram video, the deep learning model comprising a convolutional neural network and at least one dense layer. The echocardiogram analysis module may further include a cardiac prediction generator to generate a cardiac prediction based on video outputs generated for a plurality of input echocardiogram videos of an echocardiogram study, the cardiac prediction comprising a measurement prediction or a classification prediction.
Owner:THE BROAD INST INC +2